Post-IPO Equity Biotechnology Companies

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.

Thiogenesis Therapeutics is a clinical-stage biotech company that develops thiol-active therapeutics to treat medical diseases.

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.

Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.

Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.

Biotalys is an AgTech company that employs its proprietary AGROBODY™ technology platform to develop crop protection products.

Abivax develops medicines that alter the body's natural immune system mechanisms.

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Solana Company is a traded enterprise for digital asset management and neurotechnology innovation.

Paradigm is a global biopharmaceutical company driven to discover to improve patients’ health and quality of life

Aptahem develops aptamer-based drugs for the treatment of acute life-threatening conditions

Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function.